Veriheal

MAY 26, 2022

Dedicated to “redefining what’s possible,” the 501(c)(3) organization has provided 1:1 support and resources to over 69,000 clients as they navigated plant-powered cannabinoid therapy. Cannabis Advocacy With a Digital Twist. RoC also works to increase patients’ access to medical cannabis by helping U.S.

Advocacy 98

Advocacy Patients Clinical Trials Education 98

SpeedWeed

SEPTEMBER 17, 2021

million to assess the efficacy of Multidisciplinary Association for Psychedelic Studies (MAPS) MDMA-assisted therapy to treat traumatic brain injury (TBI). Wesana is a serious, thoughtful and ethical company engaged in the development of psychedelic-assisted therapy. Lately, MAPS research zeroed in on MDMA-assisted therapy for PTSD.

Clinical Trials 53

Clinical Trials Research and Development Therapy Treatment 53

Cannabis Law Report

SEPTEMBER 23, 2022

SB 519 has served as a successful trial balloon for a state’s psychedelic drug policy, and we’ll take the lessons we’ve learned from this session as we look to gain more support for what was a popular and evidence-based piece of legislation. Policy and Advocacy Director, MAPS . Ismail Lourido Ali, J.D.

Decriminalization 52

Decriminalization Advocacy Research and Development Education 52

Cannabis Law Report

APRIL 21, 2022

MAPS PBC is pioneering new forms of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for post-traumatic stress disorder (PTSD). MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD.

Advocacy 52

Advocacy Therapy Clinical Trials Environment 52

Cannabis Law Report

JANUARY 12, 2022

According to a recent report released by the Psychedelic Science Funders Collaborative, “Oregon’s psilocybin therapy program provides a high-quality model for psychedelic healing in a non-prescription context that could be replicated in other states.” ABOUT THE NATIONAL PSYCHEDELICS ASSOCIATION.

Research and Development 52

Research and Development Therapy Safety Clinical Trials 52

MMJ Recs

NOVEMBER 30, 2023

Clinical trials and studies are underway to examine the potential benefits and risks of MMJ as a treatment option for epilepsy. Furthermore, navigating legal and regulatory aspects, as well as seeking support from advocacy groups, is essential for parents and caregivers considering MMJ for pediatric epilepsy.

Epilepsy 105

Epilepsy Treatment Patients Strains 105

NORML

JANUARY 18, 2019

House lawmakers introduced The Medical Cannabis Research Act of 2019 (HR 601), to facilitate federally-approved clinical trials involving cannabis. Legislation is pending, House Bill 37, to permit physicians to recommend cannabis therapy to those struggling with opioid abuse or dependence. AK resident? HI resident? CO resident?

Legislation 164

Legislation Decriminalization Access Therapy 164